W. Gerald “Jerry” Austen, MD influential in the design and creation of a cardiopulmonary (heart-lung) bypass machine and the intra-aortic balloon pump at MGH as renowned cardiac surgeon Curator and reporter: Aviva Lev-Ari, PhD, RN This article is classified in the ontology of LPBI Group’s Journal PharmaceuticalIntelligence.com under the Category of Research Interviews with […]
Search Results for 'Aviva Lev-Ari, PhD, RN'
The Implications and Association of Stair Climbing with Atherosclerotic Cardiovascular Disease (ASCVD)
Posted in Cardiovascular and Vascular Systems, Cardiovascular Research, Epigenetics and Cardiovascular Risks, Frontiers in Cardiology and Cardiovascular Disorders, Origins of Cardiovascular Disease, tagged ASCVD, cardiorespiratory fitness, Cardiovascular disease, Fitness, physical activity, stairclimbing on October 6, 2023| Leave a Comment »
The Implications and Association of Stair Climbing with Atherosclerotic Cardiovascular Disease (ASCVD) Reporter: Arav Gandhi, Research Assistant 2, Domain Content: Cardiovascular Diseases, Series A Atherosclerotic Cardiovascular Disease (ASCVD) is a condition in which cholesterol builds up in the arteries to an extent that develops long-term complications for other areas of the body and in […]
Arav Gandhi, Research Assistant 2, Domain Content: Cardiovascular Diseases, Series A – PERSONAL PAGE
Posted in on September 18, 2023|
Arav Gandhi, Research Assistant 2, Domain Content: Cardiovascular Diseases, Series A https://pharmaceuticalintelligence.com/contributors-biographies/research-assistants/arav-gandhi-research-assistant-2-domain-content-cardiovascular-diseases-series-a/ On this PERSONAL PAGE you will record all your Progress first is the most recent Last is the Old records You create a Table with the following Columns: 10/31/23: Volume 1 Article Data and TTS Conversion Chapter Number Article ID Article Title Article […]
NEW GENRE Volume One: Genomics Orientations for Personalized Medicine – Series B, Volume 1
Posted in on June 20, 2022|
View on Amazon.com https://www.amazon.com/dp/B0BQGZRQ2C Audio y Texto NEW GENRE Volume One: Genomics Orientations for Personalized Medicine https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-b-frontiers-in-genomics-research/new-genre-volume-one-genomics-orientations-for-personalized-medicine-series-b-volume-1/ Original Volume One: Genomics Orientations for Personalized Medicine NEW GENRE Volume One: Genomics Orientations for Personalized Medicine This volume has the following three parts: PART A: The eTOCs in Spanish in Audio format PART B: The eTOCs in Bi-lingual format: Spanish […]
Aviva Lev-Ari, PhD, RN, Founder, LPBI Group: 1.0 & 2.0
Posted in on August 26, 2020|
Aviva Lev-Ari, PhD, RN Director & Founder Leaders in Pharmaceutical Business Intelligence (LPBI) Group https://lnkd.in/eEyn69r UPDATED on 1/20/2023 Five Bilingual BioMed e-Series – 37 volumes Curator, Book Editor & Bilingual BioMed e-Series, Editor-in-Chief: Aviva Lev-Ari, PhD, RN English Edition: 18 volumes in 17 books, and Spanish Edition (EDICIÓN EN ESPAÑOL): 19 volumes in 19 books https://pharmaceuticalintelligence.com/five-bilingual-biomed-e-series/ UPDATED […]
Testimonial on the English to Spanish Translation JOINT Project that yielded the “BioMed e-Series Spanish-language Edition” on Amazon.com
Posted in BioMed e-Books e-Series by LPBI Group, LPBI Group Founder - Aviva Lev-Ari on May 24, 2023| Leave a Comment »
Testimonial on the English to Spanish Translation JOINT Project that yielded the “BioMed e-Series Spanish-language Edition” on Amazon.com Interviewer: Verónica Oliver hola@veronicaoliver.es Interviewee: Aviva Lev-Ari, PhD, RN, Founder, LPBI Group AvivaLev-Ari@alum.Berkeley.edu POST 23/5 – TESTIMONIO AVIVA LEV-ARI, PhD, RN [Edited version] “A miracle that came true”. This is how Aviva Lev-Ari, PhD, RN founder of LPBI Group’s described what […]
2023 Update from LPBI Group
Posted in LPBI Group, e-Scientific Media, DFP, R&D-M3DP, R&D-Drug Discovery, US Patents: SOPs and Team Management on February 21, 2022| 1 Comment »
2023 Update from LPBI Group Author & Curator: Aviva Lev-Ari, PhD, RN Picture on 2/6/2022 BIO https://pharmaceuticalintelligence.com/knowledge-portals-system-kps/aviva-lev-ari-phd-rn-founder-lpbi-group-1-0-2-0/ UPDATED on 2/12/2023 Prediction of Page downloads from 18 volumes in BioMed e-Series All volumes since date of publication on 1/1/2023: 137,000 Total for Series A: 2022 37,818 Total for Series A: 2023 43,691 Total for Series […]
percutaneous Left Ventricular Assist Device (pLVAD) – An Israeli startup, Magenta Medical, behind the world’s smallest heart pump has raised $55 million
Posted in Mechanical Assist Devices: LVAD, RVAD, BiVAD, Artificial Heart on May 5, 2023| Leave a Comment »
percutaneous Left Ventricular Assist Device (pLVAD) – An Israeli startup, Magenta Medical, behind the world’s smallest heart pump has raised $55 million Curator: Aviva Lev-Ari, PhD, RN May 3, 2023 at 8am EST Magenta Medical Closes $55M Funding Round Led by OrbiMed Funding will further Magenta’s clinical programs in support of FDA approval for world’s […]
Optimism for Future Equality of Access to Healthcare in the Inaugural address as AMA President, Jesse M. Ehrenfeld, MD, MPH | AMA 2023 Annual Meeting of House of Delegates
Posted in Accountable Care Organizations, Federal Budget Appropriations, Health Care System by Country, Health Law & Patient Safety, Health Law Policy, Healthcare costs and reimbursement, Healthcare Reform, Uninsured and Underinsured, United States on June 14, 2023| Leave a Comment »
Optimism for Future Equality of Access to Healthcare in the Inaugural address as AMA President, Jesse M. Ehrenfeld, MD, MPH | AMA 2023 Annual Meeting of House of Delegates Reporter: Aviva Lev-Ari, PhD, RN Jun 13, 2023 #physicianadvocacy #futureofhealthcare #medicine In his inaugural address as AMA President, Jesse M. Ehrenfeld, MD, MPH, highlights the need […]
Intangibles CIM
Posted in on March 14, 2023|
Intangibles CIM Confidential Information Memorandum or CIM, a marketing document CIM will highlight your company’s intangible assets and suggest how buyers can utilize them to grow, increase profits, or mitigate risk. Of course, buyers will do their own due diligence on your assets, and lots more, before closing the deal, so all assertions in the […]